FDA recall D-0474-2026

Teva Pharmaceuticals USA, Inc · Class II · drug

Product

Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3510-04 carton, NDC 0591-3510-54 pouch

Reason for recall

CGMP Deviations: use of an unapproved raw material

Distribution

Within U.S

Key facts

Status
Ongoing
Initiation date
2026-03-19
Report date
2026-04-15
Voluntary/Mandated
Voluntary: Firm initiated
Location
Parsippany, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0474-2026